Semler Scientific, INC 8-K filings

Semler Scientific reports preliminary Q1 2025 results including revenue, loss from operations, unrealized loss from Bitcoin holdings, and a contingent liability related to a DOJ settlement, while also entering into a loan agreement with Coinbase.

Semler Scientific announces its Q4 and full-year 2024 financial results, highlighting a 107% BTC Yield since July 1, 2024, and total bitcoin holdings of 3,192.

Semler Scientific announces increased bitcoin holdings, acquiring an additional 871 bitcoins and now holding a total of 3,192, alongside a YTD BTC Yield of 152.2% since July 1, 2024.

Semler Scientific has successfully completed a private offering of $100 million in convertible senior notes due 2030, including the full exercise of the initial purchasers' option.

Semler Scientific has successfully priced an upsized private offering of $85 million in convertible senior notes due 2030, with an option for initial purchasers to buy an additional $15 million.

Semler Scientific reports preliminary unaudited Q4 2024 financial results, including revenue between $12.1 million and $12.5 million, and a significant unrealized gain from Bitcoin holdings of approximately $28.9 million.

Semler Scientific announced it has increased its bitcoin holdings to 2,321, acquired an additional 237 bitcoins, and reported a BTC Yield of 99.3% since adopting its bitcoin treasury strategy.

Semler Scientific has increased its at-the-market offering by $50 million and purchased an additional 211 bitcoins, bringing its total holdings to 2,084.

Semler Scientific increased its bitcoin holdings to 1,873, acquiring 303 additional bitcoins, and reported a BTC Yield of 78.7% since adopting its bitcoin treasury strategy.

Semler Scientific announces an additional $50 million at-the-market offering and reports a 58.4% BTC yield since adopting its bitcoin treasury strategy.

Semler Scientific has increased its bitcoin holdings to 1,273, acquired an additional 215 bitcoins, and raised $21.5 million through an at-the-market equity offering.

Semler Scientific announced its third quarter 2024 financial results, highlighted by a decrease in revenue but an increase in net income, alongside further investment in Bitcoin.

Semler Scientific's stockholders approved the 2024 Stock Option and Incentive Plan and elected directors at their annual meeting on October 4, 2024.

Semler Scientific has purchased an additional 83 bitcoins for $5 million, bringing their total holdings to 1,012 bitcoins acquired for $68 million.

Semler Scientific's Q2 2024 results show a decrease in revenue and net income, alongside a significant investment in Bitcoin.

Semler Scientific has updated its disclosures to reflect its new bitcoin treasury strategy, viewing bitcoin as a reliable store of value and a compelling investment.

Semler Scientific has announced a new bitcoin treasury strategy, positioning bitcoin as its primary reserve asset and citing its potential as a store of value.

Semler Scientific has announced a new bitcoin treasury strategy, purchasing an additional 247 bitcoins for $17 million, bringing their total holdings to 828 bitcoins for $57 million.

Semler Scientific has announced a new bitcoin treasury strategy, purchasing 581 bitcoins for $40 million, and will continue to focus on its core medical products.

Semler Scientific's first quarter of 2024 saw a 13% decrease in revenue but a 22% increase in net income compared to the same period last year.

Semler Scientific announced a 20% increase in full-year revenue and a 44% increase in net income for 2023, driven primarily by sales of its QuantaFlo product.

Semler Scientific will seek a new 510(k) clearance from the FDA to expand the use of its QuantaFlo device to diagnose a broader range of cardiovascular diseases.